Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS

Recruiting now · Not applicable

Conditions studied: Chronic Fatigue Syndrome

In brief

The goal of this clinical trial is to learn if the OTC supplement, hydrogen water, works to treat the fatigue-related symptoms and functional limitations in adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). It will also examine if heart rate variability (HRV) can be used to predict who will benefit from the hydrogen water treatment. The main questions it aims to answer are: Does the OTC supplement, hydrogen water, work to reduce the fatigue-related symptoms and improve functioning in participants who have ME/CFS? Can HRV be used to predict who will benefit from treatment with hydrogen water?

Key facts

Study ID
NCT07009691
Run by
Stony Brook University
People needed
50
Starts
2025-06-09
Expected to finish
2026-05-31
Last updated by the study team
2025-06-08

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.